Microphysiological Engineering of 3D Vascularized Human Tissues to Study Complex Diseases 08:10 - 09:00 PDT / 11:10 - 12:00 EDT / 16:10 - 17:00 BST
Mark Bertagnolli is the Chief Operating Officer of ViroMissile and serves on its board of directors, having served previously as the Company’s Chief Business Officer. Before ViroMissile, Mark was founder of Amitech Therapeutic Solutions, a small molecule biotechnology company, after serving as Genelux Corporation’s Chief Business Officer, where he worked with ViroMissile’s founder, Dr. Nanhai George Chen.
Mark earned a Bachelor of Science in Aerospace Engineering, cum laude, from the University of Michigan, Ann Arbor, and is a Certified Director by NACD.